Agency Forms Undergoing Paperwork Reduction Act Review, 58736-58737 [2024-15967]
Download as PDF
58736
Federal Register / Vol. 89, No. 139 / Friday, July 19, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Number of
respondents
Form name
Self-Perception Surveys and other Structured Questions: Perceived comfort level with technology, perceived safety and trust level with technology, perceived fatigue while interacting with technology, etc.
Biomechanics measurements: Force plate, strain
gauges, stopwatch, accelerometers (including
dataloggers), electromyography sensors human/
equipment interaction forces, whole-body motion,
Electromyography (EMG) for muscle activity, Near-infrared spectroscopy (NIRS) for muscle oxygenation,
etc.
Task Performance Measures: Measures recorded
using various virtual reality systems (e.g., Vive, Meta
quest) and components (e.g., controllers) that quantify the subjects’ performance such as time to complete, errors, movement path, and omissions.
Eye Tracking Measures: Recorded using various virtual
reality glasses (e.g., Ergoneers) to assess eyes-offtask time and recognition in response to simulated
environments designed to assess integration of new
robotic technologies and design set-up.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–15966 Filed 7–18–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–0978]
ddrumheller on DSK120RN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Emerging
Infections Program (EIP)’’ to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on February
29, 2024 to obtain comments from the
public and affected agencies. CDC
received one non-substantive comment.
This notice serves to allow an additional
30 days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
VerDate Sep<11>2014
18:53 Jul 18, 2024
Jkt 262001
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
4,000
6
10/60
2,000
4
30/60
2,000
12
15/60
2,000
12
15/60
Proposed Project
Emerging Infections Program (EIP)
(OMB Control No. 0920–0978, Exp. 2/
28/2026)—Revision—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs
(EIP) are population-based centers of
excellence established through a
network of state health departments
collaborating with academic
institutions; local health departments;
public health and clinical laboratories;
infection control professionals; and
healthcare providers. EIPs assist in
local, state, and national efforts to
prevent, control, and monitor the public
health impact of infectious diseases.
Activities of the EIPs fall into the
following general categories: (1) active
surveillance; (2) applied public health
epidemiologic and laboratory activities;
(3) implementation and evaluation of
pilot prevention/intervention projects;
and (4) flexible response to public
health emergencies. Activities of the
EIPs are designed to: (1) address issues
that the EIP network is particularly
suited to investigate; (2) maintain
sufficient flexibility for emergency
response and new problems as they
arise; (3) develop and evaluate public
health interventions to inform public
health policy and treatment guidelines;
(4) incorporate training as a key
function; and (5) prioritize projects that
lead directly to the prevention of
disease. Activities in the EIP Network to
which all applicants must participate
are:
E:\FR\FM\19JYN1.SGM
19JYN1
58737
Federal Register / Vol. 89, No. 139 / Friday, July 19, 2024 / Notices
• Active Bacterial Core surveillance
(ABCs): active population-based
laboratory surveillance for invasive
bacterial diseases.
• Foodborne Diseases Active
Surveillance Network (FoodNet): active
population-based laboratory
surveillance to monitor the incidence of
select enteric diseases.
• Influenza: active population-based
surveillance for laboratory confirmed
influenza-related hospitalizations.
• Healthcare-Associated InfectionsCommunity Interface (HAIC)
surveillance: active population-based
surveillance for healthcare-associated
pathogens and infections.
A Revision is being submitted to make
existing collection instruments clearer
and to add several new forms
specifically surveying laboratory
practices. These forms will allow the
EIP to better detect, identify, track
changes in laboratory testing
methodology, gather information about
laboratory utilization in the EIP
catchment area to ensure that all cases
are being captured, and survey EIP staff
to evaluate program quality.
CDC requests OMB approval for an
estimated 41,483 annual burden hours.
There is no cost to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form No.
Form name
State Health Department .....................
ABC.100.1 .......
ABC.100.2 .......
ABCs Case Report Form ..............................................
ABCs Invasive Pneumococcal Disease in Children
and Adults Case Report Form.
ABCs H. influenzae Neonatal Sepsis Expanded Surveillance Form.
ABCs Severe GAS Infection Supplemental Form ........
ABCs Neonatal Infection Expanded Tracking Form .....
FoodNet Campylobacter ...............................................
FoodNet Cyclospora .....................................................
FoodNet Listeria monocytogenes .................................
FoodNet Salmonella ......................................................
FoodNet Shiga toxin producing E. coli .........................
FoodNet Shigella ...........................................................
FoodNet Vibrio ..............................................................
FoodNet Yersinia ..........................................................
FoodNet Hemolytic Uremic Syndrome .........................
FoodNet Clinical Laboratory Practices and Testing
Volume.
FluSurv-Net Influenza Hospitalization Surveillance
Network Case Report Form.
FluSurv-Net Influenza Hospitalization Surveillance
Project Vaccination Phone Script and Consent Form
(English/Spanish).
FluSurv-Net Influenza Hospitalization Surveillance
Project Provider Vaccination History Fax Form (Children/Adults)and notification letter.
FluSurv-NET Laboratory Survey ...................................
HAIC—Multi-site Gram-Negative Surveillance Initiative
(MuGSI) Case Report Form (CRF).
HAIC MuGSI CA CP–CRE Health interview ................
HAIC MuGSI Supplemental Surveillance Officer Survey.
HAIC—Invasive Staphylococcus aureus Infection
Case Report Form.
HAIC—Invasive Staphylococcus aureus Laboratory
Survey.
HAIC—Invasive Staphylococcus aureus Supplemental
Surveillance Officers Survey.
HAIC—CDI Case Report and Treatment Form ............
HAIC—Annual Survey of Laboratory Testing Practices
for C. difficile Infections.
HAIC—CDI Annual Surveillance Officers Survey .........
HAIC—Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey (LTCF).
HAIC Candidemia Case Report Form ..........................
HAIC—Laboratory Testing Practices for Candidemia
Questionnaire.
HAIC Death Ascertainment Project ..............................
ABC.100.3 .......
ABC.100.4 .......
ABC.100.5 .......
FN.200.1 .........
FN.200.2 .........
FN.200.3 .........
FN.200.4 .........
FN.200.5 .........
FN.200.6 .........
FN.200.7 .........
FN.200.8 .........
FN.200.9 .........
FN.200.10 .......
FSN.300.1 .......
FSN.300.2 .......
FSN.300.3 .......
FSN.300.4 .......
HAIC.400.1 ......
HAIC.400.2 ......
HAIC.400.3 ......
HAIC.400.4 ......
HAIC.400.5 ......
HAIC.400.6 ......
HAIC.400.7 ......
HAIC.400.8 ......
HAIC.400.9 ......
HAIC.400.10 ....
HAIC.400.11 ....
HAIC.400.12 ....
HAIC.400.13 ....
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
respondents
Type of respondent
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–15967 Filed 7–18–24; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
18:53 Jul 18, 2024
Jkt 262001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FM\19JYN1.SGM
19JYN1
Number of
responses per
respondent
Average
burden per
response
(in hours)
10
10
809
127
20/60
10/60
10
6
10/60
10
10
10
10
10
10
10
10
10
10
10
10
136
37
970
42
16
855
290
234
46
55
10
70
20/60
20/60
21/60
10/60
20/60
21/60
20/60
10/60
10/60
10/60
1
10/60
15
576
25/60
13
16
10/60
13
126
5/60
15
11
16
1,581
10/60
29/60
10
11
10
1
30/60
20/60
10
788
29/60
10
11
9/60
10
1
11/60
10
10
1,650
16
38/60
17/60
10
10
1
45
15/60
5/60
10
10
170
20
40/60
14/60
10
8
24
Agencies
[Federal Register Volume 89, Number 139 (Friday, July 19, 2024)]
[Notices]
[Pages 58736-58737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15967]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-0978]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Emerging Infections Program (EIP)'' to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on February 29, 2024 to obtain
comments from the public and affected agencies. CDC received one non-
substantive comment. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Emerging Infections Program (EIP) (OMB Control No. 0920-0978, Exp.
2/28/2026)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIP) are population-based centers
of excellence established through a network of state health departments
collaborating with academic institutions; local health departments;
public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases. Activities of the EIPs fall into the
following general categories: (1) active surveillance; (2) applied
public health epidemiologic and laboratory activities; (3)
implementation and evaluation of pilot prevention/intervention
projects; and (4) flexible response to public health emergencies.
Activities of the EIPs are designed to: (1) address issues that the EIP
network is particularly suited to investigate; (2) maintain sufficient
flexibility for emergency response and new problems as they arise; (3)
develop and evaluate public health interventions to inform public
health policy and treatment guidelines; (4) incorporate training as a
key function; and (5) prioritize projects that lead directly to the
prevention of disease. Activities in the EIP Network to which all
applicants must participate are:
[[Page 58737]]
Active Bacterial Core surveillance (ABCs): active
population-based laboratory surveillance for invasive bacterial
diseases.
Foodborne Diseases Active Surveillance Network (FoodNet):
active population-based laboratory surveillance to monitor the
incidence of select enteric diseases.
Influenza: active population-based surveillance for
laboratory confirmed influenza-related hospitalizations.
Healthcare-Associated Infections-Community Interface
(HAIC) surveillance: active population-based surveillance for
healthcare-associated pathogens and infections.
A Revision is being submitted to make existing collection
instruments clearer and to add several new forms specifically surveying
laboratory practices. These forms will allow the EIP to better detect,
identify, track changes in laboratory testing methodology, gather
information about laboratory utilization in the EIP catchment area to
ensure that all cases are being captured, and survey EIP staff to
evaluate program quality.
CDC requests OMB approval for an estimated 41,483 annual burden
hours. There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form No. Form name Number of responses per per response
respondents respondent (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Health Department........................... ABC.100.1................. ABCs Case Report Form... 10 809 20/60
ABC.100.2................. ABCs Invasive 10 127 10/60
Pneumococcal Disease in
Children and Adults
Case Report Form.
ABC.100.3................. ABCs H. influenzae 10 6 10/60
Neonatal Sepsis
Expanded Surveillance
Form.
ABC.100.4................. ABCs Severe GAS 10 136 20/60
Infection Supplemental
Form.
ABC.100.5................. ABCs Neonatal Infection 10 37 20/60
Expanded Tracking Form.
FN.200.1.................. FoodNet Campylobacter... 10 970 21/60
FN.200.2.................. FoodNet Cyclospora...... 10 42 10/60
FN.200.3.................. FoodNet Listeria 10 16 20/60
monocytogenes.
FN.200.4.................. FoodNet Salmonella...... 10 855 21/60
FN.200.5.................. FoodNet Shiga toxin 10 290 20/60
producing E. coli.
FN.200.6.................. FoodNet Shigella........ 10 234 10/60
FN.200.7.................. FoodNet Vibrio.......... 10 46 10/60
FN.200.8.................. FoodNet Yersinia........ 10 55 10/60
FN.200.9.................. FoodNet Hemolytic Uremic 10 10 1
Syndrome.
FN.200.10................. FoodNet Clinical 10 70 10/60
Laboratory Practices
and Testing Volume.
FSN.300.1................. FluSurv-Net Influenza 15 576 25/60
Hospitalization
Surveillance Network
Case Report Form.
FSN.300.2................. FluSurv-Net Influenza 13 16 10/60
Hospitalization
Surveillance Project
Vaccination Phone
Script and Consent Form
(English/Spanish).
FSN.300.3................. FluSurv-Net Influenza 13 126 5/60
Hospitalization
Surveillance Project
Provider Vaccination
History Fax Form
(Children/Adults)and
notification letter.
FSN.300.4................. FluSurv-NET Laboratory 15 16 10/60
Survey.
HAIC.400.1................ HAIC--Multi-site Gram- 11 1,581 29/60
Negative Surveillance
Initiative (MuGSI) Case
Report Form (CRF).
HAIC.400.2................ HAIC MuGSI CA CP-CRE 10 10 30/60
Health interview.
HAIC.400.3................ HAIC MuGSI Supplemental 11 1 20/60
Surveillance Officer
Survey.
HAIC.400.4................ HAIC--Invasive 10 788 29/60
Staphylococcus aureus
Infection Case Report
Form.
HAIC.400.5................ HAIC--Invasive 10 11 9/60
Staphylococcus aureus
Laboratory Survey.
HAIC.400.6................ HAIC--Invasive 10 1 11/60
Staphylococcus aureus
Supplemental
Surveillance Officers
Survey.
HAIC.400.7................ HAIC--CDI Case Report 10 1,650 38/60
and Treatment Form.
HAIC.400.8................ HAIC--Annual Survey of 10 16 17/60
Laboratory Testing
Practices for C.
difficile Infections.
HAIC.400.9................ HAIC--CDI Annual 10 1 15/60
Surveillance Officers
Survey.
HAIC.400.10............... HAIC--Emerging 10 45 5/60
Infections Program C.
difficile Surveillance
Nursing Home Telephone
Survey (LTCF).
HAIC.400.11............... HAIC Candidemia Case 10 170 40/60
Report Form.
HAIC.400.12............... HAIC--Laboratory Testing 10 20 14/60
Practices for
Candidemia
Questionnaire.
HAIC.400.13............... HAIC Death Ascertainment 10 8 24
Project.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-15967 Filed 7-18-24; 8:45 am]
BILLING CODE 4163-18-P